Skip to main content
. 2021 May 31;13(11):2735. doi: 10.3390/cancers13112735

Figure 5.

Figure 5

Overview of adoptive cell therapy in the clinic. Patient’s T cells or NK cells are harvested and subsequently manipulated ex-vivo, to enable them to identify and eliminate cancer cells. The activated T cells can be then genetically reprogrammed by transduction with a construct encoding CAR or TCR, and then the cells are further expanded. Finally, the cells are reinfused into patients.